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Inflammatory Destruction of Elastic Fibers
in Acquired Cutis Laxa Is Associated with
Missense Alleles in the Elastin and Fibulin-5 Genes
Qirui Hu1, Jean-Louis Reymond2, Nicole Pinel3, Marie-Therese Zabot4 and Zsolt Urban1
Cutis laxa (CL) is a condition characterized by redundant, pendulous, and inelastic skin. Acquired CL has been
reported in patients with inflammatory diseases. The goal of this study was to investigate whether genetic
lesions predispose patients to the development of acquired CL. We report a patient who developed CL
following a Toxocara canis parasitism. He later had an aortic root aneurysm that required surgical correction.
Histological evaluation showed inflammation followed by destruction of elastic fibers in both the skin and the
aorta. Mutational analysis showed that the patient was heterozygous for an inherited fibulin-5 (FBLN5) allele
G202R and compound heterozygous for elastin (ELN) alleles A55V and G773D. Western blotting indicated
abnormal proteolytic processing of tropoelastin (TE) in patient fibroblasts. The FBLN5 202R allele on the other
hand led to increased interaction of FBLN5 and TE and increased deposition of insoluble ELN partially rescuing
the deficiency conferred by ELN mutation G773D. We demonstrated that the interaction of ELN and FBLN5
alleles results in elastic fibers susceptible to inflammatory destruction. These results suggest that the
pathogenesis of acquired CL involves an underlying genetic susceptibility and highlight the importance of
molecular genetic analysis in patients with idiopathic connective tissue disorders.
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INTRODUCTION
Acquired cutis laxa (CL) is a clinical condition characterized
by pendulous, redundant, or coarsely wrinkled areas of skin,
which usually affects adults, although isolated pediatric cases
have been reported (Lewis et al., 2004). In about half of the
cases, skin laxity is preceded by an inflammatory phase
indicated by the presence of erythematous papules or plaques
(Lewis et al., 2004). Acquired CL frequently leads to systemic
elastolysis, causing aortic rupture, emphysema, intestinal
diverticula, and hernias.
Systemic inflammatory diseases, including celiac disease
(Garcia-Patos et al., 1996), allergic reactions to penicillin
(Kerl et al., 1983) or isoniazid therapy (Koch and Williams,
1985), systemic lupus erythematosus (Randle and Muller,
1983), rheumatoid arthritis (Rongioletti et al., 2002), Borrelia
burgdorferi infection (Ozkan et al., 1999), multiple myeloma
(Cho and Maguire, 1980), and lymphoma (Chartier et al.,
1997), often precede the skin inflammation associated with
acquired CL. These conditions are of high prevalence in the
general population. The contrastingly low incidence of
acquired CL suggests that inflammation may be necessary
but not sufficient to cause elastic fiber destruction in this
disease.
We hypothesized that alleles in genes responsible for
inherited forms of CL may cause genetic susceptibility to
acquired CL. Consistent with this hypothesis, we now present
a patient with acquired CL preceded by Toxocara canis
parasitism and chronic urticaria, where molecular genetic
analysis reveals inherited mutations in the elastin (ELN) and
fibulin-5 (FBLN5) genes that result in functional alterations in
the corresponding gene products. Taken together, these
findings suggest that the pathogenesis of acquired CL requires
both genetic susceptibility and prior inflammatory disease in
affected patients.
T. canis is an ascarid nematode whose definitive host is
the domestic dog (Despommier, 2003). Ingestion of T. canis
eggs by humans results in an incomplete life cycle
characterized by hatching of eggs into larvae, but a failure
to develop into adult worms. Larvae migrate throughout the
body and cause damage in whatever organ they enter. Two
main syndromes of toxocariasis are known: visceral larva
migrans, which covers diseases associated with major organs,
and ocular larva migrans, in which the disease is restricted to
the eye and optic nerve. Death of migrating larvae triggers
delayed- and immediate-type hypersensitivity responses.
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Significant association of urticaria with toxocariasis has been
reported (Humbert et al., 2000), but the possibility of the
development of subsequent acquired CL has not been
described yet.
RESULTS
Case history
A 12-year-old boy (proband) without previous skin lesions or
other systemic involvement was first seen after he had been
suffering from urticaria for 6 months (Figures 1a and b).
Laboratory studies identified blood hypereosinophilia
(222103/ml), positive antinuclear antibodies (1/100), hypo-
complementemia (C1q, C4, C3), cryoglobulinemia (IgA,
fibronectin), and hyper-IgE globulinemia (41,000 U/ml).
Serological tests were strongly positive for Toxocara antigens,
leading to the diagnosis of visceral larva migrans. Thiaben-
dazole was administered and itching gradually decreased
with a very slow improvement of immunological abnormal-
ities. One year after the onset of urticaria and 4 months after
the initiation of treatment, a physical examination revealed
CL. The generalized wrinkling and laxity of the skin
associated with this disease gave this young man an elderly
appearance (Figure 1c).
Skin fibroblasts were collected at this time for functional
and mutational studies. Serum elastase inhibitor, a1-anti-
trypsin, and serum copper levels were within normal values.
Lung function, as assessed by carbon monoxide transfer rates,
was normal. The patient underwent facial plasty at the age of
14. In the same year, a chest X-ray examination revealed an
aortic root aneurysm. At the age of 19 years, rapid expansion
of the aneurysm required prosthetic replacement of the root
(Bentall operation). Peripheral adenomegaly and a tumor in
the left clavicle were diagnosed in the proband as symptoms
of B cell lymphoblastic lymphoma at 21 years. Chemo-
therapy resulted in total remission and persistent azoospermia
as a side effect.
Skin and aortic pathology
Histological evaluation of a skin biopsy taken during the
inflammatory phase showed intense perivascular infiltrates
(Figure 2b) containing both cells of lymphocytic and
monocytic morphology (Figure 2c). The direct immunofluor-
escence test was negative for autoantibodies (not shown).
Shortly after the development of CL, histology confirmed
the loss of elastic fibers in the dermis and decreased
Figure 1. Development of cutis laxa. The patient, shown here at the age of 12
years, was first seen with an inflammatory condition characterized by
erythematous papules affecting the entire skin including (a) the legs and
(b) the arms. Six months later, he developed generalized cutis laxa
(c) characterized by marked sagging and wrinkling of the skin.
Figure 2. Skin disease progression: histology and electron microscopy.
(a) Verhoeff van Giesson staining of normal skin sections showed abundant,
thick elastic fibers in the deep dermis (arrows) and finer, branching fibers
(arrowheads) in the papillary dermis running perpendicular to the
dermal–epidermal junction. (b) The inflammatory phase in the skin of the
patient was characterized by abundant perivascular infiltrates (arrowheads),
and the destruction of elastic fibers of which only a few fragments remained
(shaded arrows). (c) High magnification images showed both cells with
lymphocytic (black arrowheads) and monocytic (black arrows) morphology
within the infiltrates. Macrophage-like cells were closely associated with
elastic fiber fragments (shaded arrows), and occasionally contained elastic
fiber fragments (shaded arrowhead). (d) Shortly after the development of
cutis laxa, no Verhoeff van Giesson-detectable elastic fibers were observed
and inflammation subsided (arrowheads). (e) One year after the
development of cutis laxa, further remodeling of the skin is observed with
abundant deposition of ground substance and focal paucity of cells in the
papillary dermis (blue arrowhead). Incomplete recovery of the elastic fiber
system is indicated by the parallel orientation of elastic fibers with the
dermal–epidermal junction in the papillary dermis (shaded arrowheads) and
scarcity of elastic fibers (shaded arrows). Electron microscopy of skin biopsy
specimens (f) at the time of and (g) 1 year after the development of cutis laxa
showed macrophage-like cells (cell) with internalized and degraded elastic
fibers (ef). The rest of the extracellular matrix (ecm) including collagen fibrils
appeared to be unaffected. Bars: (a, b, d, and e) 100mm, (c) 20 mm, and
(f and g) 1 mm.
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inflammatory reaction (Figure 2d). One year after the
development of CL, the patient’s skin showed incomplete
repair of elastic fibers and abnormal remodeling character-
ized by increased ground substance and focal paucity of cells
in the upper dermis (Figure 2e). Electron microscopy of skin
biopsies collected both immediately after CL development
(Figure 2f) and 1 year later (Figure 2g) revealed elastic fibers
being internalized and degraded by macrophages.
The aortic aneurysm removed from the patient was
characterized by inflammation and destruction of elastic
lamellae in the media and of both collagen and elastic fibers
in the adventitia (Figure 3b). The medial elastic fiber
degradation appeared to progress from both intimal and
adventitial directions. The inner 15 and the outer
3
5 of the media
completely lacked elastic lamellae. Localized, massive
inflammatory infiltrates (Figures 3c and d) were seen in the
adventitia along with the enlargement of vasa vasorum in the
adventitia, the development of sinusoids, and granulomatous
remodeling of media (Figure 3b). Inflammatory infiltrates
were similar to those seen in the skin during the inflammatory
phase and were localized to areas of elastic fiber destruction
(Figure 3d).
Mutational studies
Screening of ELN by denaturing high-performance liquid
chromatography and direct DNA sequencing revealed two
missense alleles (164C4T, A55V and 2318G4A, G773D),
both in heterozygous state, affecting the first nucleotides of
both exons 4 and 36. Alanine 55 is conserved in mammals,
while glycine 773 is conserved in both mammalian and avian
ELN (Figure 4a). A55V is a conservative substitution and
G773D is nonconservative. A55V was not found in 183
normal individuals, whereas one of 180 controls was found to
be heterozygous for G773D.
Direct sequence analysis of FBLN5 identified a missense
allele (604G4A) in exon 5, predicted to result in a G202R
substitution in the linker peptide loop between the third and
fourth calcium-binding epidermal growth factor-like (cbEGF-like)
Figure 3. Aortic aneurysmal pathology in cutis laxa. (a) Verhoeff van
Giesson-stained aortic sections from a 15-year-old control individual with
transposition of the great arteries showed normal morphology characterized
by a thin intima (int), a media (med) rich in elastic fibers, and an adventitia
(adv) containing a dense connective tissue rich in collagen, elastic fibers, and
a loose connective tissue layer in central to peripheral order. (b) Verhoeff van
Giesson staining of the aneurysmal aortic root removed from the cutis laxa
patient at age 19 revealed thickened media and adventitia. Abundant
perivascular inflammatory infiltrates (blue arrowheads), enlargement of vasa
vasorum (arrows), and the development of sinusoids (shaded arrowheads) in
the media were associated with severe destruction of the elastic lamellae
leading to granulomatous remodeling of the media. Degradation of both
elastic and collagen fibers led to loosening of the adventitial connective
tissue. (c) Focal masses of inflammatory cells were observed at the border of
the media and adventitia in the lesional aorta. (d) Focal destruction of elastic
lamellae in the media was associated with the invasion of the media layer by
capillaries (arrow) and infiltration of inflammatory cells, which surrounded
elastic fiber fragments (arrowhead). Bars: (a and b) 200 mm, (c) 100 mm, and
(d) 20mm.
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Figure 4. Missense alleles in the elastin (ELN) and fibulin-5 genes.
(a) Multiple alignment of vertebrate ELN sequences shows conservation of
alanine 55 in mammals and of glycine 773 in both mammals and birds
affected by substitutions A55V and G773D, respectively. (b) Multiple
alignment of fibulins (FBLN) and a corresponding pair of calcium-binding
epidermal growth factor (cbEGF)-like domains in fibrillin-1 (FBN1) shows
conservation of glycine 202 in fibulin-5, -1, and -2, but not in fibulin-3, -4 and
fibrillin-1. (c) Glycine 202 (arrow) is located on the surface of the predicted
three-dimensional structure of a pair of cbEGF domains (Downing et al.,
1996), in the linker region between domains cbEGF 3 and cbEGF 4. (d) The
patient inherited the A55V ELN allele from his mother and both the G773D
ELN and the G202R FBLN5 allele from his father.
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domains. Substitution of G202R was not found in
141 normal control individuals. The G202 residue is
conserved in mammalian and avian FBLN5 molecules, in
FBLN-1 and -2 (Figure 4b). In contrast, the residue is not
conserved in FBLN-3 and -4 and in comparable cbEGF-like
domains in fibrillin-1. Residue G202 is predicted to be
located at the surface of the three-dimensional structure of
a pair of cbEGF-like domains determined by nuclear
magnetic resonance analysis of comparable polypeptides
from fibrillin-1 (Figure 4c) (Downing et al., 1996).
Genotyping of the parents of the proband (CL-23) revealed
that the ELN A55V allele was inherited from the mother and
both ELN G773D and FBLN5 G202R alleles were inherited
from the father (Figure 4d). Neither of the parents exhibited
CL or related systemic involvement or had prior inflammatory
disease.
Functional studies
To investigate the functional consequences of ELN alleles
164C4T and 2318G4A, we first studied their relative
expression by comparing sequence traces obtained from
genomic DNA and complementary DNA and found approxi-
mately equal expression (data not shown). Since both alleles
affect the first nucleotide of exons 4 and 36, respectively, we
calculated the splice site scores for each allele using a
published method, which gives a maximum score of 100 for
perfect match with the consensus sequence (Senapathy et al.,
1990). The scores for each allele were as follows: 164C¼
90.3, 164T¼89.9, 2318G¼91.6, and 2318A¼88.2, in-
dicating only minor reduction in the wild-type score. Both the
164C and the 164T scores were close to that of the acceptor
site of the downstream intron 4 (90.0), suggesting that the
164C4T substitution is unlikely to trigger exon skipping.
Experimental evaluation of splicing by RT-PCR using primers
flanking exons 4 and 36 individually indicated no alteration
relative to controls (data not shown).
The expression of tropoelastin (TE), the soluble precursor
of ELN, was evaluated in EDTA extracts of extracellular
matrix (ECM) and in cell lysates from normal control and
patient fibroblasts (Figure 5a). TE was recoverable from cell
lysates from each sample as a characteristic doublet or triplet
of isoforms of 65–68 kDa in comparable amounts. In contrast,
EDTA extraction liberated little TE from the ECM in control
cells, whereas in CL-23, a lower molecular weight
(60–62 kDa) immunoreactive protein was extracted, suggest-
ing that missense TE in this patient may undergo proteolytic
cleavage that facilitates its release from the ECM. Recently
published studies show that mutation G773D indeed
introduces cathepsin D and neutrophil elastase cleavage
sites into the C-terminal domain of TE, known to be important
in ELN deposition (Kelleher et al., 2005). Immunofluorescent
staining of cultured dermal fibroblasts, however, indicated
abundant deposition of elastic fibers by both CL-23 fibro-
blasts (Figure 5d), suggesting that the expected effect of
mutation G773D on abnormal deposition of TE was rescued
in CL-23 cells.
We compared the expression of FBLN5 in fibroblasts
from CL-23 and a normal control using immunoblotting
(Figure 5b). Cell lines were either treated with tunicamycin,
an antibiotic that inhibits N-glycosylation, or left untreated.
Cell lysates of normal cells revealed a doublet of FBLN5 with
an apparent mass of 64–66 kDa corresponding to fully
glycosylated protein. Following tunicamycin treatment,
normal cell lysates also showed a 54 kDa immunoreactive
protein, corresponding to FBLN5 lacking N-glycosylation.
The same protein was seen in lysates of both treated and
untreated CL-23 fibroblasts, suggesting that the G202R
mutation interferes with the glycosylation of FBLN5.
To further investigate the effect of G202R on the
interaction of FBLN5 with TE, we expressed wild type and
mutant FBLN5 in COS-7 cells. Using a C-terminal 6-histidine
tag, we purified the recombinant proteins. Immunoblot
analyses with both anti-c-Myc and anti-FBLN5 demonstrated
that both proteins had an apparent molecular mass of 70 kDa
corresponding to a 66 kDa FBLN5 and a 4 kDa C-terminal
Myc-His-tag, suggesting that COS-7 cells were capable of
fully glycosylating both the wild-type and the mutant protein
(data not shown). Solid-phase binding assays demonstrated
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Figure 5. Effect of missense alleles on tropoelastin (TE) and fibulin-5
synthesis and interaction. (a) Immunoblotting for TE of EDTA extracts of
extracellular matrix (ECM) and of cell lysates (Cell) from the patient (CL-23),
and from a normal control. Molecular weight marker sizes are indicated in
kilodaltons (left). The double line (right) indicates the position of normal TE
isoforms and the arrow shows abnormally processed TE. (b) Immunoblotting
for fibulin-5 of cell lysates of fibroblasts from CL-23 (heterozygous for G202R)
and a normal control cultured in the absence (T) or presence (Tþ ) of
tunicamycin. Measured molecular weights indicated in kilodaltons (right).
The arrow indicates unglycosylated fibulin-5. (c) Immunofluorescent staining
of normal and (d) CL-23 fibroblasts for elastin showing more robust elastic
fibers in CL-23. (e) Solid-phase binding assay of recombinant wild-type or
mutant (G202R) fibulin-5 to immobilized recombinant TE indicating
increased affinity of G202R fibulin-5. (f) Pulse-chase labeling of insoluble
elastin in RFL-6 cells transfected with wild-type or mutant (G202R) fibulin-5.
Cultures were labeled for 40 minutes and were cultured to the indicated time
points. Insoluble elastin was isolated, hydrolyzed, and counted by liquid
scintillation.
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increased binding of the G202R mutant protein to TE
compared to wild type (Figure 5e).
We also studied the effect of the G202R mutation on ELN
deposition. Rat fetal lung fibroblast cells (RFL-6) were
transfected with wild-type or G202R mutant human FBLN5.
Transfected cells were labeled using tritiated leucine and ELN
deposition was monitored from 0 to 24 hours after labeling,
by biochemical isolation and counting of labeled insoluble
ELN. RFL-6 cells transfected with the mutant FBLN5
deposited a more insoluble ELN compared to cells trans-
fected with wild-type FBLN5 (Figure 5f).
The colocalization of recombinant FBLN5 with endogen-
ous ELN was also investigated in RFL-6 cells by immuno-
fluorescent staining (Figure 6). Both 202G and 202R FBLN5
showed colocalization with ELN in the ECM (Figures 6a and
b). Similarly to CL-23 fibroblasts (Figure 5f), RFL-6 cells
transfected with mutant plasmid showed more robust elastic
fiber network (Figure 6b) than cells transfected with the wild-
type construct (Figure 6a). Interestingly, in permeabilized
cells, wild-type FBLN5 was localized in a different sub-
cellular compartment than TE (Figure 6c). In contrast, 202R
FBLN5 showed strong intracellular colocalization with TE
(Figure 6d), suggesting early interaction of 202R FBLN5 with
TE in the secretory pathway. TE is known to be unglyco-
sylated. Thus, intracellular binding and cotrafficking of TE
and FBLN5 may prevent the glycosylation of FBLN5 in
elastogenic cells.
In interpreting the studies dissecting the effect of the 202R
allele in FBLN5 on TE binding and deposition, we realize that
the experiments were conducted using either 202G or 202R
FBLN5. In contrast, patient CL-23 was heterozygous for
G202R and therefore patient cells synthesize equimolar
amounts of 202G and 202R protein. Thus, the presence of
the wild-type FBLN5 is expected to attenuate the positive
effect of 202R FBLN5 on TE binding and deposition.
Nevertheless, similar morphology of elastic fibers in CL-23
fibroblasts (Figure 5d) and RFL-6 cells transfected with 202R
FBLN5 (Figure 6b and d) suggests that this mutation can exert
its effect even in the presence of wild-type FBLN5.
DISCUSSION
Our studies document a coexistence of genetic alterations in
ELN, FBLN5, and an inflammatory condition prior to the
development of acquired CL in a young man with preceding
T. canis parasitism. While inflammatory etiology of acquired
CL has been recognized (Lewis et al., 2004), this is the first
demonstration of an association of genetic lesions with the
disease process. The finding that the genetic changes in this
patient occur at evolutionarily conserved residues, were not
present in control samples, and resulted in abnormal
processing of TE and FBLN5 directly implicate these
alterations in the pathogenesis of CL. Consistent with this
conclusion, studies have demonstrated that mutations in
either ELN (Tassabehji et al., 1998; Zhang et al., 1999;
Rodriguez-Revenga et al., 2004; Szabo et al., 2005; Urban
et al., 2005) or FBLN5 (Loeys et al., 2002; Markova et al.,
2003) can cause CL. Furthermore, the apparent lack of CL or
other connective tissue abnormalities in the proband’s
parents, each of whom carried one or more of these
mutations, as well as the failure to detect CL in individuals
heterozygous for FBLN5 missense mutations (Loeys et al.,
2002), strongly supports the hypothesis that the connective
tissue abnormalities observed in our patient required both the
identified genetic alterations and the inflammatory insult.
Recently published results and our own data shed some
light on the role of the missense alleles identified in our
patient in the development of acquired CL. The ELN G773D
allele has recently been described in a family with severe
early-onset emphysema (Kelleher et al., 2005). At least one
mutation-positive family member also had pronounced skin
laxity. Functional analysis of G773D mutation indicated (1)
a subtle defect in deposition of mutant TE into elastic fibers,
(2) decreased cell adhesion to the mutant protein, and
(3) increased susceptibility of the mutant polypeptide to
cathepsin D and neutrophil elastase digestion. These data
suggest that the G773D may be sufficient to cause CL or a
related disease.
Figure 6. Colocalization of normal and mutant fibulin-5 with tropoelastin.
Immunostaining of RFL-6 cells transfected with (a, c) wild-type or (b, d)
G202R mutant fibulin-5 expression constructs. An anti-Myc tag monoclonal
antibody was used to detect recombinant fibulin-5 (Fibulin-5) in conjunction
with a secondary antibody conjugated to a blue fluorescent dye. TE and
elastin was detected with an anti-TE polyclonal antibody (Elastin) with a
secondary antibody conjugated to a green fluorescent dye. Nuclei were
counterstained with propidium iodide (red). (a, b) Non-permeabilized cells
showed co-localization of fibulin-5 and elastin in the extracellular matrix. The
cell line transfected with (b) mutant fibulin-5 developed more robust elastic
fibers than the cell line transfected with (a) wild-3type fibulin-5. Permeabi-
lized cultures showed intracellular and extracellular staining for both fibulin-5
and elastin. (c) In cells transfected with a wild type construct fibulin-5 was
seen in a different subcellular compartment from TE. (d) In contrast, G202R
fibulin-5 showed intracellular co-localization with TE.
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Why did our patient have normal elastic tissue function
prior to his inflammatory disease? We have shown that 202R
FBLN5 binds ELN more strongly than wild-type FBLN5,
associates with TE intracellularly, and improves the deposi-
tion of insoluble ELN. These functional changes have
probably rescued the ELN deposition and cell adhesion
defect conferred by the G773D mutation in ELN. Our studies
also show that despite abundant elastic fiber matrix, ELN
deposited by CL-23 cells is still susceptible to proteolytic
degradation. This observation might explain the rapid
destruction of elastic fibers in our patient following an
inflammatory insult.
Some of the mechanisms that may lead to specific
degradation of ELN following a nonspecific inflammatory
condition are known. Activated macrophages and neutro-
phils are known to secrete elastases such as macrophage
metalloelastase-12 (Shapiro, 1999) and neutrophil elastase
(Shapiro, 2002). Proteolytic degradation products of ELN in
turn have been shown to be chemotactic to leucocytes
(Senior et al., 1980), maintaining a positive feedback loop of
inflammation and ELN degradation. Our studies indicate that
missense variants in elastic fiber proteins may predispose to
such immune-mediated ELN destruction.
Taken together, our observations suggest that the interac-
tion of variants in the ELN and FBLN5 genes may result in an
elastic fiber system that is functionally competent but highly
susceptible to inflammatory degradation. The clinical and
molecular data presented here support the concept that
inflammatory stimuli in genetically predisposed patients may
result in acquired CL. Importantly, in a greater clinical
context, these observations raise the hypothesis that a broad
spectrum of idiopathic, acquired connective tissue disorders
such as aortic aneurysms as well as impaired regenerative
processes following tissue injury may have a similar under-
lying genetic etiology. In this regard, our findings suggest that
the ELN and FBLN5 genes are good candidates for further
genetic analysis in patients with clinically significant diffe-
rences in the response to injury, inflammation, and infection.
MATERIALS AND METHODS
Patients and samples
The patient, parents, and normal control individuals participated in
this study following informed consent. This study was conducted
according to the Declaration of Helsinki Principles and has been
approved by the Human Studies Committee of Washington
University School of Medicine. Tissue samples were collected as
skin biopsies or surgical material following aortic root replacement.
Normal control tissue samples were provided by the Cooperative
Human Tissue Network, which is funded by the National Cancer
Institute. Other investigators may have received specimens from the
same subjects. Control DNA was obtained from normal volunteers of
diverse ethnic backgrounds and included 10 French individuals to
match the ethnicity of the proband. DNA was isolated from
peripheral blood or dermal fibroblasts by isolating nuclei, followed
by proteinase K digestion and phenol extraction (Herrmann and
Frischauf, 1987).
Mutational analysis
Each exon of FBLN5 was amplified with flanking intronic sequences
(Table 1) in GeneAmp 9700 (Applied Biosystems, Foster City, CA)
PCR machines. Amplimers were subjected to direct sequence
analysis on both strands using the BigDye dye terminator cycle
sequencing chemistry (Applied Biosystems, Foster City, CA). Sub-
sequent to identifying the mutations, a normal DNA panel was
screened for variants identified in the probands using denaturing
high-performance liquid chromatography. Mutational screening of
ELN was conducted using denaturing high-performance liquid
chromatography followed by direct sequencing of variant amplimers
as described previously (Tassabehji and Urban, 2005).
Gene expression studies
For RNA and protein analyses, fibroblasts were cultured to
confluency at passages 4–8 in DMEM supplemented with 10% fetal
bovine serum, 25 mM 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic
acid (HEPES), L-glutamine, and antibiotics. Confluent cultures were
used to extract RNA using TRI-reagent (Molecular Research Center,
Cincinnati, OH). First-strand complementary DNA was synthesized
Table 1. Oligonucleotide primers for the amplification of FBLN5 exons
Exon Forward primer Reverse primer Size Anneal
1 AGAGGGCTAAGCAAAACCAG GCTTCCAGACCCTGGAGAAA 285 60
2 CAAGCCCAAGGTGATATCA GCTCAGATGAGGTCAACTGT 291 60
3 CCCCAACTTTCTGTGTTGCA CCATGGGCATGGCTAATCAT 235 60
4 CCTGGTACCGAGTTCTGCTT TGGTGAGCATGCCAGATACA 413 60
5 CTGCCTCCCAGCCAAGATGA CAGCTATGCCCATACCTCAA 300 60
6 GATCCTGTTTGGGAAGAGCA AGCTGCCAGGTGCTGAAGAA 286 60
7 GGGAGGACAGTCAGCAATGT CCCCAAGTACAGGTGGAAGT 199 60
8 CAGTGTGAGAGTTGGAGTAGA CCAGGTGAGGATATCCAGAT 294 60
9 TATGGCCTGTTGCTGCCATA GGCTGGTGCACTCTCTTTCA 342 60
10 GGTGGCCTCATTTTCAGTGT TCCTAGGAGAGACAGCACAA 355 60
11 GAAAGAGCATGGCACAGTTG GTCTGTGTCGCTCTCATTCT 386 60
Size=size of PCR products in base pairs; Anneal=annealing temperature in degrees Celsius.
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from total RNA samples (1 mg each) using SuperScript III reverse
transcriptase (Invitrogen, Grand Island, NY). For PCR amplification
of ELN complementary DNA, the following oligonucleotide primers
were used: exon 1 forward 50-GGG TCT GAC GGC GGC GGC C-30,
exon 6 reverse 50-AGG TAA CTG CGG GGA AGG CG-30, exon 9
reverse 50-GCA CGC CAC CTG GTA TAC A-30, exon 26 forward
50-GCT GGT GTT CCT GGC TTC G-30, exon 31 forward 50-GTA TAC
CTC CAG CTG CAG CCG-30, and exon 36 reverse 50-TTC TCT TCC
GGC CAC AAG CT-30. Standard PCR reactions used Pfx polymerase
(Invitrogen, Grand Island, NY) under the conditions recommended by
the manufacturer with annealing temperatures of 601C.
Immunoblotting
Cells were cultured in 75 cm2 tissue culture flasks as described for
RNA isolation. For tunicamycin treatment, fibroblasts were cultured
in DMEM medium until 90–95% confluence. Tunicamycin (Sigma,
St Louis, MO) was added at a final concentration of 5mg/ml, and
cells were cultured for an additional 4 days before isolation of
lysates. To extract ECM, the cell layers were washed using 10 ml
prewarmed phosphate-buffered saline two to three times and 2 ml of
10 mM EDTA (pH 8.0) in phosphate-buffered saline was added,
followed by shaking at room temperature for 5 minutes. The EDTA
extract was centrifuged at 2,000 g for 10 minutes. To bind and
concentrate soluble proteins, the supernatant was transferred to a
new tube and was mixed and incubated with 10 ml StrataClean Resin
(Stratagene, La Jolla, CA) at room temperature for 30 minutes. The
resin was pelleted and was resuspended in 2 Laemmli loading
buffer and boiled for 3 minutes prior to loading onto SDS-PAGE.
Subsequently, to isolate intracellular proteins, flasks were placed on
ice, and 500 ml fresh lysis buffer (phosphate-buffered saline, 0.5%
NP-40, 1 mM ammonium molybdate, 1 mM 4-(2-aminoethyl)-benzene-
sulfonyl fluoride hydrochloride, 50 mM NaF, 1mg/ml leupeptin, 1mg/
ml pepstatin A, 1 mg/ml phenylmethylsulfonyl fluoride) was added
to each of the flasks. The cells were scraped from the flask and the
lysates were homogenized on ice in dounce homogenizers. The
protein concentration of the lysate was determined using the
Bradford method. Protein aliquots (40mg) were mixed with an equal
volume of 2 Laemmli loading buffer and boiled for 3 minutes prior
to loading onto SDS-PAGE. After electrophoresis, the proteins were
transferred onto polyvinylidene fluoride membranes. The blots were
blocked using fat-free milk in Tris-buffered saline Tween (TBST,
150 mM NaCl, 20 mM Tris-HCl, pH 7.5, 0.1% Tween-20) and rabbit
anti-FBLN5 IgG (1:500, a kind gift of Dr Robert Mecham), or rabbit
anti-ELN IgG (PR533; Elastin Product Company, Owensville, MO)
was incubated with the blot for 1 hour in fresh blocking solution.
The blot was washed using TBST, and horseradish-peroxidase-
conjugated secondary antibody (1:30,000, #674371; ICN Biomedi-
cal, Costa Mesa, CA) was added to the blot in fresh blocking
solution. Antibody binding was detected using a chemiluminescent
kit (ECL, Amersham Biosciences, Piscataway, NJ).
Solid-phase binding assay
This study utilized recombinant bovine TE (a kind gift of Dr Robert
Mecham) and human FBLN5 protein. FBLN5 was expressed in
transfected COS-7 cells using pcDNA 3.1 (Invitrogen, Grand Island,
NY) as an expression vector. Recombinant FBLN5 had C-terminal
c-Myc and His tags and was purified by Ni-column chromatography.
TE (100 ng/well) was coated onto 96-well plates in TBS (Tris-buffered
saline, 20 mM Tris/HCl, pH 7.4, and 0.15 M NaCl) at 41C for
4–8 hours. Nonspecific binding was blocked by incubating with 6%
BSA in TBS/1%Tx100 overnight at 41C. FBLN dilutions were added
for 2 hours at room temperature. Then, anti-c-Myc primary antibody
(Invitrogen) and horseradish-peroxidase-conjugated secondary anti-
body were added in turn. Wells were washed three times with TBS/
1%Tx100 after each step. Color was developed using tetramethyl-
benzidine (Sigma) and stopped using 2 M sulfuric acid. Plates were
read at a wavelength of 450 nm. Each experimental group included
four negative controls, without either TE, FBLN5, primary antibody,
or secondary antibody. The mean of negative control readings was
subtracted from the experimental readings.
Insoluble ELN assays
Transfected RFL-6 cells were plated onto 60 mm culture dishes
(100,000 cells/dish) and grown to confluence for 3 days. Cell
cultures were washed with warm phosphate-buffered saline,
incubated in DMEM/Leu/5% dialyzed fetal bovine serum for
30 minutes, and 20 ml H3-leucin (20mCi) was added to each dish.
Cells were cultured for 40 minutes and were washed with
phosphate-buffered saline. Fresh complete medium was added at
0, 2, 4, 8, 16, and 24 hours following the labeling pulse, cell cultures
belonging to each experimental group were terminated, and
insoluble ELN was assessed. After removal of the medium, cell
layers were washed in 0.1 M acetic acid and then scraped in 0.1 N
NaOH, centrifuged, and pellets were resuspended in 0.5 ml of 0.1 N
NaOH and boiled for 45 minutes. The resulting pellets containing
the insoluble ELN were hydrolyzed by boiling in 5.7 N HCl for
1 hour. Aliquots taken from each sample were mixed with
scintillation fluid and counted.
Histology and immunofluorescent staining
Tissue samples of aorta and skin were cut to 5-mm-thick sections.
Sections were deparaffinized in Histo-Clear (National Diagnostics,
Atlanta, GA) and rehydrated. All histological sections were stained
using Verhoeff’s van Giesson method (Poly Scientific, Bay Shore,
NY), which shows elastic fibers as black, collagen as red, muscle,
cornified epithelium as yellow, and nuclei as dark blue. Immuno-
fluorescent staining of cultured fibroblasts was conducted as
described previously (Urban et al., 2005).
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